oral DPP9 inhibitor

in vitro synergy with NNRTI for HIV

from 250k cmpd phenotypic screen

ACS Chem. Biol.

Merck, Rahway, NJ

ICeD-2 chemical structure oral DPP9 inhibitor - Merck, Rahway, NJ

Context. ICeD-2 (Merck) is a dipeptidyl peptidase 9 (DPP9) inhibitor under development for HIV-1 infections. Despite the significant advancements in antiretroviral therapy research leading to the approval of some…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: